Abiopharma

CareDx - CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

STERIS Announces Chief Financial Officer Transition

AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference

STERIS Announces Financial Results for Fiscal 2026 First Quarter

Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference

Ecolab Inc. - Ecolab Appoints Julie Whalen to Board of Directors

Surrozen to Present at Upcoming Healthcare Investor Conference

Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy

Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update

Cross Country Healthcare Announces Second Quarter 2025 Financial Results

Enhabit Home Health & Hospice - Enhabit Home Health & Hospice Announces CEO Transition Plan

Brookdale Senior Living Inc. - Brookdale Announces Second Quarter 2025 Results and Increases Annual Guidance

Keros to Exclusively Prioritize the Clinical Advancement of KER-065